Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Development of a Standardized Acupuncture Tool Inspired by Advanced Techniques for Improved Safety and Precision
Published on: January 10, 2025
Barriers to the Adoption of Safety-Engineered Needles Following a Regulatory Standard: Lessons Learned from Three
Andrea Chambers1, Cameron A Mustard2, D Linn Holness3
1Doctoral Student, Institute for Work and Health Toronto, ON.
Background:
A number of jurisdictions have introduced regulation to accelerate the adoption of safety-engineered needles (SENs). This study examined the transition to SENs in three acute care hospitals prior to and following the implementation of a regulatory standard in Ontario. This paper focuses on the ongoing barriers to the prevention of needlestick injuries among healthcare workers.
Methods:
Information from document review and 30 informant interviews were used to prepare three case studies detailing each organization's implementation activities and outcomes.
Results:
All three hospitals responded to the regulatory requirements with integrity and needlestick injuries declined. However, needlestick injuries continued to occur during the activation of safety devices, during procedures and during instrument disposal. The study documented substantial barriers to further progress in needlestick injury prevention.
Conclusions:
Healthcare organizations should focus on understanding their site-specific challenges that contribute to ongoing injury risk to better understand issues related to product limitations, practice constraints and the work environment.
Related Concept Videos
Drug Regulation
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Drug Products: Biologics, Biosimilars and Interchangeables
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
FDA Approved Drugs: Changes to Approved Drugs

